Recent Press Releases

Abbott's HUMIRA® (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study

ABBOTT PARK, Ill., May 10, 2011 /PRNewswire/ -- Abbott's (NYSE: ABT) HUMIRA® (adalimumab) met its primary endpoint of clinical remission in a Phase III study of adult patients with moderate to severe

Pfenex Announces Strategic Collaboration With MedImmune for the Use of Pfenex Expression Technology™

SAN DIEGO, May 10, 2011 /PRNewswire/ -- Pfenex Inc., an industry leader in protein expression through the Pfenex Expression Technology™ platform, announced today a three year strategic collaboration

Alzheimer’s Association Salutes Advocate And Mountaineer Now Climbing Everest As Part Of The 7 Summits Climb For Alzheimer

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc., together with its collaborator on the Alzheimer’s Immunotherapy Program, Janssen Alzheimer Immunotherapy, is pleased to announce the Alzheimer’s Association™,

BioSante Pharmaceuticals Reports First Quarter Financial Results and Recent Developments

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)-- BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today reported on its financial results for the first quarter, cash balance as of March 31, 2011 and recent

Electrical Impedance as a Novel Biomarker of Myotube Atrophy and Hypertrophy

- Measured with Roche´s xCELLigence System PENZBERG, Germany--(BUSINESS WIRE)-- Tracking physiological changes in skeletal muscle thickness is a direct and unbiased approach in screening therapeutic

American Regent Resumes Shipment of Injectable Products

American Regent Resumes Shipment of Injectable Products American Regent announced today that it had resumed the shipment of its multisource injectable products on May 5, 2011. Release of

DSC Logistics Forms Health Care Strategy Board

DSC Logistics Forms Health Care Strategy Board Experts will consult with DSC leaders on expanding role in health care supply chain management CHICAGO--(BUSINESS WIRE)-- DSC Logistics has announced

Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Receives CE Mark

WIESBADEN, Germany, May 10, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has received CE Mark (Conformite Europeenne) for its new FreeStyle InsuLinx Blood Glucose Monitoring

Phase 3 Clinical Trial Data of Lubiprostone in Japanese Patients with Chronic Idiopathic Constipation Presented at DDW 201

BETHESDA, Md. & ABBOTT PARK, Ill.--(BUSINESS WIRE)-- Sucampo Pharmaceuticals, Inc. (“Sucampo”) (NASDAQ: SCMP) and Abbott (NYSE: ABT) today reported data from a phase 3 clinical efficacy trial in

Forest and Almirall to Present Data from Phase III Studies of Aclidinium Bromide in Chronic Obstructive Pulmonary Disease

--Data to be presented at 2011 American Thoracic Society International Conference-- NEW YORK--(BUSINESS WIRE)-- Forest Laboratories, Inc. (NYSE: FRX) and Almirall, S.A. (ALM.MC) today announced that

Age-Based Screening for Hepatitis C Virus Could Lead to Fewer Cases of Advanced Liver Disease and Related Deaths, Accordin

Age-based screening would extend lives at relatively low cost of $25,279 per quality-adjusted life-year gained; 1.6 million U.S. residents ages 40-64 are infected with hepatitis C virus but are

Merck Announces Hope Against Hepatitis C Initiative to Support Public Awareness, Education and Research in the Fight Again

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the launch of Hope Against Hepatitis C, a company initiative to

Pfizer’s Prevnar 13® Meets All Study Endpoints In Two Pivotal Phase 3 Trials In Adults Aged 50 And Older Presented T

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE:PFE) today announced that the data from its two pivotal Phase 3 immunogenicity and safety trials of Prevnar 13®*(Pneumococcal 13-valent Conjugate Vaccine

Reportlinker Adds U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments

NEW YORK, May 9, 2011 /PRNewswire/ -- announces that a new market research report is available in its catalogue: U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New

Roche Submits Application for Clearance of Chlamydia and Gonorrhoeae Test

Test detects and expands menu on the recently approved cobas 4800 instrumentPLEASANTON, Calif., May 6, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has filed for

New Device to Support Blood Circulation for Heart Patients Shows Improved Outcomes Compared to Current Treatment

Goal to Reduce Heart's Workload and Increase Blood Flow for High-Risk PCI PatientsBALTIMORE, May 6, 2011 /PRNewswire/ -- A new device designed to assist blood circulation and support blood pressure

Sandoz builds oral contraceptive portfolio with the launch of Loryna®, a generic version of YAZ®

Sandoz builds oral contraceptive portfolio with the launch of Loryna®, a generic version of YAZ®Princeton, New Jersey, May 04, 2011 Sandoz today announced the US Food and Drug Administration

Abbott Receives FDA Approval to Expand Use of the RX ACCULINK® Carotid Stent System to Patients at Standard Surgical Risk

- Expanded Indication Supported by Results from the CREST Trial, Which Demonstrated Similar Safety and Efficacy for Stenting and SurgeryABBOTT PARK, Ill., May 6, 2011 /PRNewswire/ -- Abbott (NYSE:

Study Shows Stents Are Superior to Balloons Alone for Patients With Deep Venous Thrombosis

EVISTA-DVT Trial Shows High-Grade Stenosis in Veins Treated With Stents After Thrombolysis More Than Twice as Likely to Stay OpenBALTIMORE, May 6, 2011 /PRNewswire/ -- Stenting is safe and effective

NICE consults on commonly used expensive drugs for leukaemia

NICE consults on commonly used expensive drugs for leukaemiaIn new draft guidance, published today, NICE has not been able to recommend dasatinib, high-dose imatinib or nilotinib for the treatment of